News
Interview of Pr. Mordon during the EADV congress
Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.
Analysis phase of PHOS-ISTOS clinical trial is now achieved
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
Enrollment phase of INDYGO is now successfully achieved
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
English Channel swimming and pleural cancer
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
Special issue of the Lasers in Surgery and Medicine journal
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
Industrial development of PhoS-Istos project
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
Serge Mordon meets the High Commissionner of the CEA
Visit of Prof. Bréchet to northern france branch of the CEA to discuss relationships with local actors in research and innovation
OncoThAI at the ASLMS 2018 annual congress in Dallas, TX
OncoThAI researchers presented their latest works during the ASLMS 2018 conference in Dallas
OncoThAI work reported in the French weekly journal Le Point (April 5th, 2018)
OncoThAI work reported in the French weekly journal Le Point (April 5th, 2018)
Page 5 of 8
